Australia's most trusted
source of pharma news
Thursday, 12 March 2026
Posted 2 August 2024 AM
There have been sixteen additions to the PBS this month with three innovative drugs making their debut.
Onpattro has become the first of Alnylam's portfolio of RNAi medicines to be subsidised in Australia. The drug now sponsored by Medison Pharma in Australia is intended for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.